Praxbind Cost Without Insurance — US Pharmacy Price Guide

Our most recent US pharmacy data shows a low of roughly $5,091.95 for Praxbind with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Generic and brand-name pricing for Praxbind is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The cost of Praxbind under an insurance plan is highly variable and depends on the specifics of your coverage. Some plans may cover it fully or with a copay, while others may require prior authorization or not cover it at all. Medicare and Medicaid coverage also varies by plan. The best way to determine your cost is to contact your insurance provider directly for details on medication coverage, formulary status, and any patient assistance requirements. If your plan does not cover Praxbind or imposes a high out-of-pocket cost, you can discuss alternative payment strategies with your pharmacist, such as using a pharmacy savings card or investigating manufacturer patient assistance programs, to help manage the expense.

No. Praxbind (idarucizumab) is only available as a brand-name medication produced by Boehringer Ingelheim. There is no FDA-approved generic equivalent available at this time. As a specialized reversal agent with a specific patent, it is unlikely a generic alternative will be available in the near future. Patients seeking to reduce the cost must therefore explore savings options for the brand-name product.